MedTrace Logo

Genomic and Dietary Aspects in Gastric Cancer Risk

NCT05934058 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 383980

Last updated 2023-07-06

No results posted yet for this study

Summary

Gastric Cancer (GC) ranks fourth in the number of deaths worldwide and it is sixth in Italy with almost 9,000 deaths in 2020. Survival of GC is one of the lowest reported amongst major cancers, thus making prevention a central priority for its control. However there is currently a lack of evidence on gastric cancer determinants.

Our study will pursue the following specific objectives:

* analyze dietary and lifestyle habits for GC, also infrequent ones (WP1);
* analyze major risk factors in rare patient subgroups (WP2);
* develop a Genome-wide Modelling of polygenic risk score (PRS) in GC (WP3)

Conditions

Sponsors & Collaborators

  • University of Bologna

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Stefania Boccia, PhD · IRCCS Fondazione Policlinico Universitario Agostino Gemelli

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2025-01-25
Completion
2027-07-25

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05934058 on ClinicalTrials.gov